The MTNR1B rs10830963 Variant in Interaction with Pre-Pregnancy BMI is a Pharmacogenetic Marker for the Initiation of Antenatal Insulin Therapy in Gestational Diabetes Mellitus

Documenti analoghi

• Association Study with 77 SNPs Confirms the Robust Role for the rs10830963/G of MTNR1B Variant and Identifies Two Novel Associations in Gestational Diabetes Mellitus Development
  di: Rosta, Klara, et al.
  Pubblicazione: (2017)
• Identification and Potential Clinical Utility of the MTNR1B rs10830963 Core Gene Variant Associated to Endophenotypes in Gestational Diabetes Mellitus
  di: Gábor Firneisz, et al.
  Pubblicazione: (2020-04-01)
• Identification and Potential Clinical Utility of the MTNR1B rs10830963 Core Gene Variant Associated to Endophenotypes in Gestational Diabetes Mellitus
  di: Firneisz, Gábor, et al.
  Pubblicazione: (2020)
• Comments on: A functional polymorphism rs10830963 in melatonin receptor 1B associated with the risk of gestational diabetes mellitus
  di: Rosta, Klara, et al.
  Pubblicazione: (2020)
• Increased Proportion of Hematopoietic Stem and Progenitor Cell Population in Cord Blood of Neonates Born to Mothers with Gestational Diabetes Mellitus
  di: Hadarits, Orsolya, et al.
  Pubblicazione: (2016)